Literature DB >> 29127233

Vascular endothelial function masks increased sympathetic vasopressor activity in rats with metabolic syndrome.

Sylvain Battault1, Cindy Meziat1, Allesandro Nascimento1, Laura Braud2, Sandrine Gayrard1, Christian Legros3, Frederic De Nardi3, Jocelyne Drai4, Olivier Cazorla5, Jérôme Thireau5, Gregory Meyer1, Cyril Reboul1.   

Abstract

Sympathetic hyperactivation, a common feature of obesity and metabolic syndrome, is a key trigger of hypertension. However, some obese subjects with autonomic imbalance present a dissociation between sympathetic activity-mediated vasoconstriction and increased blood pressure. Here, we aimed to determine in a rat model of metabolic syndrome whether the endothelium endothelial nitric oxide (NO) synthase (eNOS)-NO pathway contributes to counteract the vasopressor effect of the sympathetic system. Rats were fed a high-fat and high-sucrose (HFS) diet for 15 wk. Sympathovagal balance was evaluated by spectral analysis of heart rate variability and plasmatic catecholamine measurements. Blood pressure was measured in the presence or absence of N-nitro-l-arginine methyl ester (l-NAME) to inhibit the contribution of eNOS. Vascular reactivity was assessed on isolated aortic rings in response to α1-adrenergic agonist. The HFS diet increased sympathetic tone, which is characterized by a higher low on the high-frequency spectral power ratio and a higher plasmatic concentration of epinephrine. Despite this, no change in blood pressure was observed. Interestingly, HFS rats exhibited vascular hyporeactivity (-23.6%) to α1-adrenergic receptor stimulation that was abolished by endothelial removal or eNOS inhibition (l-NAME). In addition, eNOS phosphorylation (Ser1177) was increased in response to phenylephrine in HFS rats only. Accordingly, eNOS inhibition in vivo revealed higher blood pressure in HFS rats compared with control rats (147 vs. 126 mmHg for mean blood pressure, respectively). Restrain of adrenergic vasopressor action by endothelium eNOS is increased in HFS rats and contributes to maintained blood pressure in the physiological range. NEW & NOTEWORTHY Despite the fact that prohypertensive sympathetic nervous system activity is markedly increased in rats with early metabolic syndrome, they present with normal blood pressure. These observations appear to be explained by increased endothelial nitric oxide synthase response to adrenergic stimulation, which results in vascular hyporeactivity to α-adrenergic stimulation, and therefore blood pressure is preserved in the physiological range. Listen to this article's corresponding podcast at http://www.physiology.org/doi/10.1152/ajpheart.00217.2017 .

Entities:  

Keywords:  endothelium; hypertension; metabolic syndrome; nitric oxide; sympathetic activation

Mesh:

Substances:

Year:  2017        PMID: 29127233     DOI: 10.1152/ajpheart.00217.2017

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  11 in total

1.  TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice.

Authors:  Zachary I Grunewald; Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Salvador Mejia; Camila Manrique-Acevedo; Ulrich Siebenlist; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

2.  Chronic Elevation of Endothelin-1 Alone May Not Be Sufficient to Impair Endothelium-Dependent Relaxation.

Authors:  Zachary I Grunewald; Thomas J Jurrissen; Makenzie L Woodford; Francisco I Ramirez-Perez; Lauren K Park; Ryan Pettit-Mee; Thaysa Ghiarone; Scott M Brown; Mariana Morales-Quinones; James R Ball; Kevin F Staveley-O'Carroll; Annayya R Aroor; Paul J Fadel; Pierre Paradis; Ernesto L Schiffrin; Shawn B Bender; Luis A Martinez-Lemus; Jaume Padilla
Journal:  Hypertension       Date:  2019-10-21       Impact factor: 10.190

Review 3.  Skeletal muscle performance in metabolic disease: Microvascular or mitochondrial limitation or both?

Authors:  Jefferson C Frisbee; Matthew T Lewis; Robert W Wiseman
Journal:  Microcirculation       Date:  2018-12-23       Impact factor: 2.628

4.  Brief overview of dietary intake, some types of gut microbiota, metabolic markers and research opportunities in sample of Egyptian women.

Authors:  Nayera E Hassan; Salwa M El Shebini; Sahar A El-Masry; Nihad H Ahmed; Ayat N Kamal; Ahmed S Ismail; Khadija M Alian; Mohammed I Mostafa; Mohamed Selim; Mahmoud A S Afify
Journal:  Sci Rep       Date:  2022-10-14       Impact factor: 4.996

5.  Male and female high-fat diet-fed Dahl SS rats are largely protected from vascular dysfunctions: PVAT contributions reveal sex differences.

Authors:  Stephanie W Watts; Emma S Darios; G Andres Contreras; Hannah Garver; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-30       Impact factor: 5.125

6.  Intrinsic exercise capacity induces divergent vascular plasticity via arachidonic acid-mediated inflammatory pathways in female rats.

Authors:  Vaishnavi Aradhyula; Emily Waigi; Nicole R Bearss; Jonnelle M Edwards; Bina Joe; Cameron G McCarthy; Lauren B Koch; Camilla F Wenceslau
Journal:  Vascul Pharmacol       Date:  2021-04-16       Impact factor: 5.738

Review 7.  Effects of Intermittent Hypoxia on Pulmonary Vascular and Systemic Diseases.

Authors:  Hiroshi Kimura; Hiroyo Ota; Yuya Kimura; Shin Takasawa
Journal:  Int J Environ Res Public Health       Date:  2019-08-26       Impact factor: 3.390

Review 8.  The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?

Authors:  Lorena Perrone; Mariarosaria Valente
Journal:  Biomolecules       Date:  2021-11-08

Review 9.  Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System.

Authors:  Benedetta Russo; Marika Menduni; Patrizia Borboni; Fabiana Picconi; Simona Frontoni
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

10.  Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats.

Authors:  Iwona Baranowska; Olga Gawrys; Agnieszka Walkowska; Krzysztof H Olszynski; Luděk Červenka; John R Falck; Adeniyi M Adebesin; John D Imig; Elżbieta Kompanowska-Jezierska
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.